| abstract |
It is disclosed a Juniperus communis extract comprising agathadiol, and pharmaceutical compositions comprising said extract, for use in the prevention and/or treatment of a disease or condition responsive to positive allosteric modulators (PAM) of cannabinoid type 1 receptor (CB 1R). Additionally, disclosed is agathadiol, as well as pharmaceutical compositions comprising the same, for use in the prevention and/or treatment of a disease or condition responsive to positive allosteric modulators cannabinoid type 1 receptor. Finally, also disclosed are nutraceutical compositions comprising agathadiol, or a Juniperus communis extract comprising the same, for preventing or alleviating the symptoms of a disease or condition responsive to positive allosteric modulators cannabinoid type 1 receptor. |